Parametric Portfolio Associates’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-72,110
| Closed | -$12.4M | – | 3747 |
|
|
2021
Q3 | $12.4M | Buy |
72,110
+11,326
| +19% | +$1.48M | 0.01% | 1215 |
|
|
2021
Q2 | $7.63M | Sell |
60,784
-1,410
| -2% | -$178K | ﹤0.01% | 1579 |
|
|
2021
Q1 | $8.43M | Buy |
62,194
+8,715
| +16% | +$1.13M | ﹤0.01% | 1799 |
|
|
2020
Q4 | $6.84M | Buy |
53,479
+5,257
| +11% | +$616K | ﹤0.01% | 1859 |
|
|
2020
Q3 | $5.43M | Sell |
48,222
-1,160
| -2% | -$115K | ﹤0.01% | 1837 |
|
|
2020
Q2 | $4.71M | Buy |
49,382
+395
| +0.8% | +$38.1K | ﹤0.01% | 1917 |
|
|
2020
Q1 | $4.4M | Buy |
48,987
+9,500
| +24% | +$738K | ﹤0.01% | 1828 |
|
|
2019
Q4 | $2.09M | Buy |
39,487
+1,756
| +5% | +$80.1K | ﹤0.01% | 2662 |
|
|
2019
Q3 | $1.49M | Buy |
37,731
+10,385
| +38% | +$451K | ﹤0.01% | 2808 |
|
|
2019
Q2 | $1.12M | Buy |
27,346
+3,352
| +14% | +$139K | ﹤0.01% | 2998 |
|
|
2019
Q1 | $1.12M | Sell |
23,994
-28,029
| -54% | -$1.23M | ﹤0.01% | 2975 |
|
|
2018
Q4 | $2.27M | Buy |
52,023
+778
| +2% | +$38.9K | ﹤0.01% | 2500 |
|
|
2018
Q3 | $2.93M | Buy |
51,245
+46,355
| +948% | +$2.28M | ﹤0.01% | 2431 |
|
|
2018
Q2 | $237K | Buy |
+4,890
| New | +$178K | ﹤0.01% | 3647 |
|
|
2017
Q4 | – | Sell |
-27,672
| Closed | -$1.03M | – | 3962 |
|
|
2017
Q3 | $1.03M | Buy |
27,672
+18,216
| +193% | +$632K | ﹤0.01% | 3024 |
|
|
2017
Q2 | $287K | Buy |
9,456
+355
| +4% | +$10.3K | ﹤0.01% | 3649 |
|
|
2017
Q1 | $241K | Buy |
+9,101
| New | +$240K | ﹤0.01% | 3526 |
|
|
2016
Q4 | – | Sell |
-8,401
| Closed | -$304K | – | 3819 |
|
|
2016
Q3 | $304K | Sell |
8,401
-396
| -5% | -$13.1K | ﹤0.01% | 3411 |
|
|
2016
Q2 | $299K | Buy |
8,797
+90
| +1% | +$2.93K | ﹤0.01% | 3453 |
|
|
2016
Q1 | $230K | Buy |
8,707
+1,264
| +17% | +$36.8K | ﹤0.01% | 3707 |
|
|
2015
Q4 | $363K | Buy |
+7,443
| New | +$268K | ﹤0.01% | 3455 |
|